Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Oct;64(4):764–768. doi: 10.1038/bjc.1991.395

Influence of the antioestrogen tamoxifen on normal breast tissue.

K J Walker 1, J M Price-Thomas 1, W Candlish 1, R I Nicholson 1
PMCID: PMC1977690  PMID: 1911227

Abstract

Immunohistochemical assays have been employed to study the expression of ER, PgR, EGFR and Ki67 immunostaining in normal breast tissue (n = 76). The expression of ER and PgR was highly variable in both pre and postmenopausal women and was characterised by large numbers of apparently negative cells. This was most evident for ER-ICA staining in tissues removed from premenopausal women. PgR levels were highest in the ducts of premenopausal women, while EGFR expression was elevated in both ducts and lobules. Ki67 expression was observed in less than 10% of all normal cells and was suppressed by the menopause in lobular tissue. Tamoxifen therapy (40 mg d-1) did not influence the expression of PgR, EGFR or Ki67 immunostaining in cancer associated normal tissue (n = 17). A significant increase, however, was observed in the mean percentage ER positivity in ductal tissue. No effect of duration of tamoxifen therapy was observed on the expression of the antigens studied.

Full text

PDF
764

Images in this article

766Plate 1
on p.766

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouzubar N., Walker K. J., Griffiths K., Ellis I. O., Elston C. W., Robertson J. F., Blamey R. W., Nicholson R. I. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer. 1989 Jun;59(6):943–947. doi: 10.1038/bjc.1989.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Elder J. B., Williams G., Lacey E., Gregory H. Cellular localisation of human urogastrone/epidermal growth factor. Nature. 1978 Feb 2;271(5644):466–467. doi: 10.1038/271466a0. [DOI] [PubMed] [Google Scholar]
  3. Fentiman I. S. The endocrine prevention of breast cancer. Br J Cancer. 1989 Jul;60(1):12–14. doi: 10.1038/bjc.1989.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ferrazzi E., Cartei G., Mattarazzo R., Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. Br Med J. 1977 May 21;1(6072):1351–1352. doi: 10.1136/bmj.1.6072.1351-e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fex G., Adielsson G., Mattson W. Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol (Copenh) 1981 May;97(1):109–113. doi: 10.1530/acta.0.0970109. [DOI] [PubMed] [Google Scholar]
  6. Furr B. J., Jordan V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25(2):127–205. doi: 10.1016/0163-7258(84)90043-3. [DOI] [PubMed] [Google Scholar]
  7. Gerdes J., Lelle R. J., Pickartz H., Heidenreich W., Schwarting R., Kurtsiefer L., Stauch G., Stein H. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol. 1986 Sep;39(9):977–980. doi: 10.1136/jcp.39.9.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Götze S., Nishino Y., Neumann F. Anti-oestrogenic effects of tamoxifen on mammary gland and hypophysis in female rats. Acta Endocrinol (Copenh) 1984 Mar;105(3):360–370. doi: 10.1530/acta.0.1050360. [DOI] [PubMed] [Google Scholar]
  9. Kasselberg A. G., Orth D. N., Gray M. E., Stahlman M. T. Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem. 1985 Apr;33(4):315–322. doi: 10.1177/33.4.3884705. [DOI] [PubMed] [Google Scholar]
  10. Katzenellenbogen B. S., Kendra K. L., Norman M. J., Berthois Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 1987 Aug 15;47(16):4355–4360. [PubMed] [Google Scholar]
  11. Lewis S., Locker A., Todd J. H., Bell J. A., Nicholson R., Elston C. W., Blamey R. W., Ellis I. O. Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol. 1990 May;43(5):385–389. doi: 10.1136/jcp.43.5.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Macias A., Perez R., Hägerström T., Skoog L. Transforming growth factor alpha in human mammary carcinomas and their metastases. Anticancer Res. 1989 Jan-Feb;9(1):177–179. [PubMed] [Google Scholar]
  13. Nicholson R. I., Gotting K. E., Gee J., Walker K. J. Actions of oestrogens and antioestrogens on rat mammary gland development: relevance to breast cancer prevention. J Steroid Biochem. 1988;30(1-6):95–103. doi: 10.1016/0022-4731(88)90081-7. [DOI] [PubMed] [Google Scholar]
  14. Pike M. C., Ross R. K., Lobo R. A., Key T. J., Potts M., Henderson B. E. LHRH agonists and the prevention of breast and ovarian cancer. Br J Cancer. 1989 Jul;60(1):142–148. doi: 10.1038/bjc.1989.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Poulsen S. S., Nexø E., Olsen P. S., Hess J., Kirkegaard P. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry. 1986;85(5):389–394. doi: 10.1007/BF00982668. [DOI] [PubMed] [Google Scholar]
  16. Powles T. J., Hardy J. R., Ashley S. E., Farrington G. M., Cosgrove D., Davey J. B., Dowsett M., McKinna J. A., Nash A. G., Sinnett H. D. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer. 1989 Jul;60(1):126–131. doi: 10.1038/bjc.1989.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sainsbury J. R., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987 Jun 20;1(8547):1398–1402. doi: 10.1016/s0140-6736(87)90593-9. [DOI] [PubMed] [Google Scholar]
  18. Sainsbury J. R., Farndon J. R., Sherbet G. V., Harris A. L. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet. 1985 Feb 16;1(8425):364–366. doi: 10.1016/s0140-6736(85)91385-6. [DOI] [PubMed] [Google Scholar]
  19. Sakai F., Cheix F., Clavel M., Colon J., Mayer M., Pommatau E., Saez S. Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. J Endocrinol. 1978 Feb;76(2):219–226. doi: 10.1677/joe.0.0760219. [DOI] [PubMed] [Google Scholar]
  20. Walker K. J., Bouzubar N., Robertson J., Ellis I. O., Elston C. W., Blamey R. W., Wilson D. W., Griffiths K., Nicholson R. I. Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res. 1988 Nov 15;48(22):6517–6522. [PubMed] [Google Scholar]
  21. Welshons W. V., Jordan V. C. Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol. 1987 Dec;23(12):1935–1939. doi: 10.1016/0277-5379(87)90062-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES